Clover Health officer plans sale of 73K shares

Clover Health Investments, Corp. (symbol CLOV) received a Rule 144 notice from officer Brady Priest covering planned sales of up to 73,516 shares of common stock, with an indicated aggregate market value of $305,113.45, around 08/31/2026.

Rhea-AI Filing Summary

Clover Health Investments, Corp. (symbol CLOV) received a Rule 144 notice from officer Brady Priest covering planned sales of up to 73,516 shares of common stock, with an indicated aggregate market value of $305,113.45, around 08/31/2026. The notice cites 435,441,337 common shares outstanding. It also reports that Priest sold 474,801 shares for an aggregate $2,171,597.33 on 08/14/2026 and 441,601 shares for $2,141,988.87 on 08/07/2026, all as common stock transactions under Rule 144.

Key Figures

Shares to be sold: 73,516 shares of common stock Aggregate market value of planned sale: $305,113.45 Shares outstanding: 435,441,337 shares +4 more

7 metrics

Shares to be sold 73,516 shares of common stock Planned Rule 144 sale around 08/31/2026

Aggregate market value of planned sale $305,113.45 For 73,516 CLOV shares covered by the notice

Shares outstanding 435,441,337 shares CLOV common shares outstanding referenced in the notice

Shares sold on 08/14/2026 474,801 shares CLOV common stock sold by Brady Priest in past three months

Aggregate sale price on 08/14/2026 $2,171,597.33 For 474,801 CLOV shares sold

Shares sold on 08/07/2026 441,601 shares CLOV common stock sold by Brady Priest in past three months

Aggregate sale price on 08/07/2026 $2,141,988.87 For 441,601 CLOV shares sold

Key Terms

Rule 144, Restricted Stock, Aggregate market value, Securities To Be Sold

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock financial

"Common | 07/18/2024 | Restricted Stock | Issuer"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Aggregate market value financial

"Common | Morgan Stanley Smith Barney LLC ... | 73516 | 305113.45 | 435441337"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Securities To Be Sold financial

"144: Securities To Be Sold"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for CLOV disclose about Brady Priest’s planned stock sale?

The filing states that officer Brady Priest plans to sell up to 73,516 shares of Clover Health Investments, Corp. common stock under Rule 144, with an indicated aggregate market value of $305,113.45, around 08/31/2026.

How many CLOV shares has Brady Priest sold in the past three months?

The notice reports sales of 474,801 CLOV common shares for $2,171,597.33 on 08/14/2026 and 441,601 shares for $2,141,988.87 on 08/07/2026.

What is the aggregate market value of the CLOV shares covered by the new Form 144?

The Form 144 indicates an aggregate market value of approximately $305,113.45 for the 73,516 CLOV common shares covered by the planned sale notice.

How many Clover Health (CLOV) shares are outstanding according to this Form 144?

The Form 144 lists 435,441,337 CLOV common shares as outstanding in connection with the Rule 144 sales information provided.

What type of CLOV securities are involved in Brady Priest’s Form 144 filing?

The filing covers common stock of Clover Health Investments, Corp., identified as restricted stock to be sold under Rule 144 through a broker, Morgan Stanley Smith Barney LLC Executive Financial Services.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/31/2026 - 04:48 PM EDT Accepted by SEC EDGAR 08/31/2026 - 04:47 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001938197
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CLOVER HEALTH INVESTMENTS, CORP.
SEC File Number	001-39252
Address of Issuer	1209 Orange Street Wilmington DELAWARE 19801
Phone	(201) 432-2133
Name of Person for Whose Account the Securities are To Be Sold	BRADY PRIEST
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	73516	305113.45	435441337	08/31/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/18/2024	Restricted Stock	Issuer			73516	07/18/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
BRADY PRIEST 1209 Orange Street Wilmington DE 19801	Common	08/14/2026	474801	2171597.33
BRADY PRIEST 1209 Orange Street Wilmington DE 19801	Common	08/07/2026	441601	2141988.87

144: Remarks and Signature

Remarks
Date of Notice	08/31/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Brady Patrick Priest
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)